Our mission is to significantly improve the lives of patients suffering from immunological disorders by providing effective and safe drugs for diseases with high unmet medical needs.
InDex Pharmaceuticals is a Swedish pharmaceutical company seeking to improve the lives of patients suffering from immunological diseases. Our mission is to develop effective and safe drugs for diseases with a significant medical need. InDex Pharmaceuticals was founded in 2000 and is located at Karolinska Institutet Science Park in Stockholm. InDex has a strong investor base with Linc AB, HBM Healthcare Investments and 4th AP Fund among its top shareholders. InDex Pharmaceuticals Holding AB (publ) is the parent company of the Group, which also includes InDex Pharmaceuticals AB and InDex Pharmaceuticals AB’s wholly owned subsidiary InDex Diagnostics AB. Additional information about our corporate governance can be found here.